This Press Release is Acting as a Correction to the Financial Tables in the Previous ReleaseCompleted all Supplemental Testing and has Submitted ...

Q4 2024 Earnings Call Transcript March 12, 2025 Larry Holub: Good afternoon everyone. I’m Larry Holub, Director at MZ North America, and would like to welcome you to the Monogram Technologies fourth ...

Value-based care providers have increasingly collaborated with health insurers to try and keep medically complex patients out ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Monogram Orthopaedics Inc (MGRM – Research ...

Monogram Orthopaedics (NASDAQ:MGRM – Get Free Report) is expected to issue its quarterly earnings data after the market closes on Wednesday, March 12th.Analysts expect the company to announce ...

Monogram has obtained FDA clearance for mPress implants and applied for 510(k) clearance for its robotic products. The Company is required to obtain FDA clearance before it can market its products.

Completed all supplemental testing and submitted its formal response to the U.S. Food and Drug Administration (FDA) regarding the Additional Information Request (AIR) received on September 30 ...

Monogram Technologies Inc. ( NASDAQ: MGRM) Q4 2024 Earnings Conference Call March 11, 2025 4:30 PM ET Larry Holub - Investor Relations Benjamin Sexson - Chief Executive Officer Noel Knape - Chief ...

AUSTIN, TEXAS / ACCESS Newswire / March 12, 2025 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an ...